# US 2025/0074861 A1 · Anticonvulsant Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0074861 A1
- Document ID: US20250074861A1
- Status: Published application
- Kind: A1
- Application number: 18/629,463
- Filed: 2024-04-08
- Published: 2025-03-06
- Earliest claimed: 2017-01-10
- Assignees: Owen-Barry Pharmaceuticals Inc.
- Applicants: Owen-Barry Pharmaceuticals Inc.
- Inventors: Michael POULTER (Deceased); Tony DURST
- Web page: https://patentgrep.com/patent/US20250074861A1

## CPC

- C07C 69/78: Benzoic acid esters
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/166: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/216: of acids having aromatic rings, e.g. benactizyne, clofibrate
- A61K 31/4453: only substituted in position 1, e.g. propipocaine, diperodon
- A61P 25/08: Antiepileptics; Anticonvulsants
- C07C 49/603: of a six-membered ring, e.g. quinone methides
- C07C 49/623: having two rings
- C07C 49/67: having two rings, e.g. tetralones
- C07C 49/683: having unsaturation outside the aromatic rings
- C07C 49/697: containing six-membered aromatic rings
- C07C 49/723: polycyclic
- C07C 49/753: containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups
- C07C 63/66: Polycyclic acids with unsaturation outside the aromatic rings
- C07C 65/32: containing keto groups
- C07C 69/157: containing six-membered aromatic rings
- C07C 69/76: Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C 235/84: with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 255/40: the carbon skeleton being further substituted by doubly-bound oxygen atoms
- C07C 317/24: having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C 321/28: Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07D 211/08: with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D 295/192: from aromatic carboxylic acids
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present application relates to compounds and methods for reducing the severity of convulsant activity or epileptic seizures, or for the treatment of chronic or acute pain.

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

A compound of formula (II):
wherein,
R1 and R2 are both CH3 or R1 is H and R2 is aryl, wherein aryl is:
phenyl, which is optionally substituted with one or two of CH3, OH, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
1- or 2-naphthyl;
2-, 3-, or 4-pyridyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
2- or 3-furyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN; or
2- or 3-thienyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
R3 is:
a straight C5 or C6 alkyl, a branched C3 to C6 alkyl, or CH(CH2)n, wherein n is an integer from 3 to 5;
CH2SC6H5;
C(O)CH(CN)CH3;
CH═CHC(O)CH3, CH═CHC(O)C6H5, CH═CHC(O)—O—CH3, CH═CHC(O)—O—C2H5, CH═CHC(O)—O—CH(CH3)2, CH═CHC(O)—O—C4H9, or CH═CHC(O)—O—C6H5;
CH(CN)CH3;
CH═CHCN; or
CH═CHSO2CH3, CH═CHSO2C6H5,
with the proviso that when R1=R2=CH3:
R3 is not a straight C5 or C6 alkyl, a branched C3 to C6 alkyl, CH(CH2)5, CH═CHC(O)CH3, CH═CHC(O)—O—CH3, or CH═CHC(O)—O—C2H5.

### Claim 34 (depends on 33)

The compound of claim 33, wherein R1 and R2 are CH3.

### Claim 35 (depends on 34)

The compound of claim 34, wherein R3 is CH(CH2)n, wherein n is 3 or 4; CH2SC6H5; CH═CHC(O)C6H5; CH═CHC(O)—O—CH(CH3)2; CH═CHC(O)—O—C4H9; or CH═CHC(O)—O—C6H5.

### Claim 36 (depends on 33)

The compound of claim 33, wherein R1 is H and R2 is aryl.

### Claim 37 (depends on 36)

The compound of claim 36, wherein R2 is phenyl, which is optionally substituted with one or two of CH3, OH, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN.
